Načítá se...
The transformation in biomarker detection and management of drug-induced liver injury
Drug-induced liver injury (DILI) is a major concern for patients, care givers and the pharmaceutical industry. Interpretation of the serum biomarkers routinely used to detect and monitor DILI, which have not changed in almost 50 years, can be improved with recently proposed models employing quantita...
Uloženo v:
| Vydáno v: | Liver Int |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5632128/ https://ncbi.nlm.nih.gov/pubmed/28386997 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/liv.13441 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|